Vitamin K2 in multiple sclerosis patients.

Reza LasemiMichael KundiNahid Beladi MoghadamHanns MoshammerJohannes A Hainfellner

Published in: Wiener klinische Wochenschrift (2018)

The substantially lower levels of VK2 in MS patients could be due to depletion, lower production in the gut, diminished absorption or, less likely, reduced intake of precursor vitamin K1. The role of VK2 in MS development and progress deserves further study.

Keyphrases

multiple sclerosis
end stage renal disease
newly diagnosed
chronic kidney disease
ejection fraction
mass spectrometry
prognostic factors
ms ms
physical activity
body mass index